Evidence Limitations and Unanswered Questions The main evidence limitations for GHK-Cu are uneven human data, formulation differences, limited injectable safety information, small topical skin studies, indirect hair evidence, and uncertain long-term outcomes [2], [6], [7], [8]
Online, it is frequently grouped with BPC-157 in what is known as the Wolverine stack recovery protocols
Fredman G, Hellmann J, Proto JD, Kuriakose G, Colas RA, Dorweiler B, et al
VEGF treatment ameliorates depression-like behavior in adult offspring after maternal immune activation
CAS 62568-57-4) was isolated in 1977 by Schoenenberger, Monnier and colleagues at the University of Basel from the cerebral venous blood of rabbits subjected to hypnogenic electrical stimulation of the intralaminar thalamus, and named for the slow-wave (delta) EEG activity it appeared to enhance after intraventricular infusion in recipient rabbits (Schoenenberger & Monnier, 1977)